Difference between revisions of "Pirinen E"
From Bioblast
Beno Marija (talk | contribs) Β |
|||
(4 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{{EAGLE | |||
|COST = Member | |||
|COST WG2=WG2 | |||
|COST WG3=WG3 | |||
|COST WG4=WG4 | |||
}} | |||
{{Person | {{Person | ||
|lastname=Pirinen | |lastname=Pirinen | ||
|firstname=Eija | |firstname=Eija | ||
|institution=University of Helsinki | |institution=UEija Pirinen laboratory, | ||
Β | |||
Research Program for Clinical and Molecular Metabolism, | |||
Β | |||
Faculty of Medicine, | |||
Β | |||
University of Helsinki, FI | |||
|address=Haartmanninkatu 8 | |||
|area code=00290 | |||
|address= | |||
|area code= | |||
|city=Helsinki | |city=Helsinki | ||
|country=Finland | |country=Finland | ||
Line 14: | Line 24: | ||
{{Labelingperson}} | {{Labelingperson}} | ||
== Participated at == | == Participated at == | ||
* [[MiPNet20.10 IOC106 Schroecken|IOC106 Schroecken]] | ::::* [[MiPNet20.10 IOC106 Schroecken|IOC106 Schroecken AT]] | ||
* [[IOC93| IOC93 Tampere]] | ::::* [[IOC93| IOC93 Tampere FI]] |
Latest revision as of 12:15, 26 November 2019
News and Events | Working Groups | Short-Term Scientific Missions | Management Committee | Members |
COST Action CA15203 (2016-2021): MitoEAGLE
Evolution-Age-Gender-Lifestyle-Environment: mitochondrial fitness mapping
Pirinen E
MitoPedia topics: EAGLE
COST: Member
COST WG2: WG2 COST WG3: WG3 COST WG4: WG4
Name | Pirinen Eija, |
---|---|
Institution | UEija Pirinen laboratory,
Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, FI |
Address | Haartmanninkatu 8, 00290 |
City | Helsinki |
State/Province | |
Country | Finland |
[email protected] | |
Weblink | |
O2k-Network Lab | FI Helsinki Pirinen E |
Labels:
Publications
Published | Reference | |
---|---|---|
Van de Weijer 2015 Diabetes | 2015 | van de Weijer T, Phielix E, Bilet L, Williams EG, Ropelle ER, Bierwagen A, Livingstone R, Nowotny P, Sparks LM, Paglialunga S, Szendroedi J, Havekes B, Moullan N, Pirinen E, Hwang JH, Schrauwen-Hinderling VB, Hesselink MK, Auwerx J, Roden M, Schrauwen P (2015) Evidence for a direct effect of the NAD+ precursor acipimox on muscle mitochondrial function in humans. Diabetes 64:1193-201. |